zydelig.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
#updated 4/06/2022 User-agent:* Sitemap: https://www.zydelig.com/sitemap.xml Sitemap: https://www.zydelig.com/image-sitemap.xml # End
Meta Tags
Title ZYDELIG® (idelalisib) Official
Description ZYDELIG® is a PI3Kδ inhibitor indicated Find information on ZYDELIG® (idelalisib). See full Prescribing Information, including BOXED
Keywords N/A
Server Information
WebSite zydelig faviconzydelig.com
Host IP 98.129.93.160
Location United States
Related Websites
Site Rank
More to Explore
zydelig.com Valuation
US$9,318,096
Last updated: 2023-05-08 15:25:49

zydelig.com has Semrush global rank of 1,135,887. zydelig.com has an estimated worth of US$ 9,318,096, based on its estimated Ads revenue. zydelig.com receives approximately 1,075,165 unique visitors each day. Its web server is located in United States, with IP address 98.129.93.160. According to SiteAdvisor, zydelig.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$9,318,096
Daily Ads Revenue US$8,602
Monthly Ads Revenue US$258,040
Yearly Ads Revenue US$3,096,475
Daily Unique Visitors 71,678
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
zydelig.com. A 299 IP: 98.129.93.160
zydelig.com. NS 86400 NS Record: ns5.netnames.net.
zydelig.com. NS 86400 NS Record: ns6.netnames.net.
zydelig.com. NS 86400 NS Record: ns1.netnames.net.
zydelig.com. NS 86400 NS Record: ns2.netnames.net.
zydelig.com. MX 86400 MX Record: 20 mail6088.gilead.mkt6687.com.
zydelig.com. MX 86400 MX Record: 10 reply.gilead.mkt6687.com.
zydelig.com. TXT 86400 TXT Record: google-site-verification=ej8SGCiop_j9qvWShbSzylXEUXuzHhQlzaufMEXLQ3M
HtmlToTextCheckTime:2023-05-08 15:25:49
Full Prescribing Information Important Safety Information Intended for US healthcare professionals only. Full Prescribing Information Important Safety Information Medication Guide View Healthcare Professional Site ZYDELIG ® is a PI3K δ inhibitor indicated for the treatment of relapsed chronic lymphocytic leukemia (CLL), in combination with rituximab, in patients for whom rituximab alone would be considered appropriate therapy due to other comorbidities. Limitations of use: ZYDELIG is not indicated and is not recommended for first-line treatment of any patient, including patients with CLL, small lymphocytic lymphoma (SLL), follicular lymphoma (FL), and other indolent non-Hodgkin lymphomas. ZYDELIG is not indicated and is not recommended in combination with bendamustine and rituximab, or in combination with rituximab for the treatment of patients with FL, SLL, and other indolent non-Hodgkin lymphomas. PI3K δ =phosphatidylinositol 3-kinase. ZYDELIG ® AccessConnect ® Patient financial
HTTP Headers
HTTP/1.1 301 Moved Permanently
Content-Length: 147
Content-Type: text/html; charset=UTF-8
Location: https://www.zydelig.com/
Server: Microsoft-IIS/10.0
X-Powered-By: ASP.NET
Date: Sat, 30 Oct 2021 06:51:26 GMT

HTTP/2 200 
cache-control: private
content-length: 32721
content-type: text/html; charset=utf-8
server: Microsoft-IIS/10.0
x-aspnetmvc-version: 5.2
x-aspnet-version: 4.0.30319
x-frame-options: SAMEORIGIN
x-content-type-options: nosniff
x-ua-compatible: IE=Edge,chrome=1
x-xss-protection: 1; mode=block
date: Sat, 30 Oct 2021 06:51:26 GMT
zydelig.com Whois Information
Domain Name: ZYDELIG.COM
Registry Domain ID: 1741404036_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.corporatedomains.com
Registrar URL: http://cscdbs.com
Updated Date: 2021-08-25T05:05:36Z
Creation Date: 2012-08-29T20:50:41Z
Registry Expiry Date: 2022-08-29T20:50:41Z
Registrar: CSC Corporate Domains, Inc.
Registrar IANA ID: 299
Registrar Abuse Contact Email: domainabuse@cscglobal.com
Registrar Abuse Contact Phone: 8887802723
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1.NETNAMES.NET
Name Server: NS2.NETNAMES.NET
Name Server: NS5.NETNAMES.NET
Name Server: NS6.NETNAMES.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-17T17:36:18Z <<<